Prognostic significance of branched-chain amino acid transferase 1 and CD133 in triple-negative breast cancer

Previous studies have shown that branched-chain amino acid transferase 1 (BCAT1) is associated with tumour progression in triple-negative breast cancer (TNBC). Furthermore, CD133 has emerged as a novel cancer stem cell marker for indicating tumour progression.